Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Cognitive Dysfunction × Ashwagandha × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Osteosarcoma 1 Cognitive Dysfunction 1 Chemotherapy-Related Cognitive Impairment 1

Interventions

Neuropsychological Tests 2 Vitamin D 1 Standard of Care 1 Physical Conditioning, Human 1 Patient Reported Outcome Measures 1 Mindfulness 1 Exergaming 1 Counseling 1 Coping Skills 1 Blood Specimen Collection 1 Aspirin 1 Ashwagandha 1 Anticonvulsants 1 Absorptiometry, Photon 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04092647 2023-06-15

Ashwagandha for Cognitive Dysfunction

Sutter Health

Phase 2 Unknown

Chemotherapy-Related Cognitive Impairment, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡